Insiders · VIGL

VIGL insider transactions

Vigil Neuroscience Inc. (VIGL) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for VIGL

• 266d
  Large owner Atlas Venture Fund Xii, L.P. returned 5,836,874 shares to the company (SEC Form 4)

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 268d
  Director Thistle Mary returned 5,000 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 268d
  SEC Form 4 filed by Chief Medical Officer Kaufmann Petra

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 268d
  Director Budd Haeberlein Samantha L. returned 17,000 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 268d
  Chief Financial Officer Ziolkowski Jennifer Lynn returned 4,000 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 268d
  Director Booth Bruce returned 5,841,874 shares to the company (SEC Form 4)

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 268d
  Director Vitorovic Stefan returned 5,000 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 268d
  President and CEO Magovcevic-Liebisch Ivana returned 222,687 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 268d
  SEC Form 4 filed by Chief Science Officer Gray David L. F.

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 268d
  Director Bruhn Suzanne Louise returned 5,000 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 268d
  Director Blanchard Cheryl R returned 5,000 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 268d
  Director Koenig Gerhard returned 5,000 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 342d
  Director Booth Bruce was granted 5,000 shares (SEC Form 4)

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 342d
  Director Vitorovic Stefan was granted 5,000 shares (SEC Form 4)

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 342d
  Director Bruhn Suzanne Louise was granted 5,000 shares (SEC Form 4)

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 342d
  Director Koenig Gerhard was granted 5,000 shares (SEC Form 4)

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 342d
  Director Budd Haeberlein Samantha L. was granted 5,000 shares, increasing direct ownership by 42% to 17,000 units (SEC Form 4)

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 342d
  Director Blanchard Cheryl R was granted 5,000 shares (SEC Form 4)

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 342d
  Director Thistle Mary was granted 5,000 shares (SEC Form 4)

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 422d
  SEC Form 4 filed by Chief Medical Officer Kaufmann Petra

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 422d
  SEC Form 4 filed by Director Bruhn Suzanne Louise

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 422d
  SEC Form 4 filed by Chief Financial Officer Ziolkowski Jennifer Lynn

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 422d
  SEC Form 4 filed by President and CEO Magovcevic-Liebisch Ivana

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 422d
  SEC Form 4 filed by Chief Science Officer Gray David L. F.

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 422d
  SEC Form 4 filed by Director Booth Bruce

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 497d
  Director Budd Haeberlein Samantha L. bought $20,520 worth of shares (12,000 units at $1.71) (SEC Form 4)

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 497d
  President and CEO Magovcevic-Liebisch Ivana bought $8,400 worth of shares (5,000 units at $1.68), increasing direct ownership by 2% to 222,687 units (SEC Form 4)

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 498d
  President and CEO Magovcevic-Liebisch Ivana bought $8,350 worth of Common Stock (5,000 units at $1.67), increasing direct ownership by 2% to 217,687 units (SEC Form 4)

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 511d
  President and CEO Magovcevic-Liebisch Ivana bought $11,700 worth of shares (5,000 units at $2.34), increasing direct ownership by 2% to 212,687 units (SEC Form 4)

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 692d
  SEC Form 4 filed by Vitorovic Stefan

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 692d
  SEC Form 4 filed by Thistle Mary

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 692d
  SEC Form 4 filed by Bruhn Suzanne Louise

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 692d
  SEC Form 4 filed by Blanchard Cheryl R

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 692d
  SEC Form 4 filed by Koenig Gerhard

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 692d
  SEC Form 4 filed by Booth Bruce

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 692d
  SEC Form 4 filed by Budd Haeberlein Samantha L.

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 723d
  SEC Form 4 filed by Vitorovic Stefan

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 723d
  SEC Form 4 filed by Verni Christopher

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 723d
  SEC Form 4 filed by Bruhn Suzanne Louise

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 723d
  SEC Form 4 filed by Booth Bruce

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 723d
  SEC Form 4 filed by Thistle Mary

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 723d
  SEC Form 4 filed by Blanchard Cheryl R

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 723d
  SEC Form 4 filed by Budd Haeberlein Samantha L.

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 723d
  SEC Form 4 filed by Gray David L. F.

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 723d
  SEC Form 4 filed by Koenig Gerhard

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 723d
  SEC Form 4 filed by Ziolkowski Jennifer Lynn

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 723d
  SEC Form 4 filed by Magovcevic-Liebisch Ivana

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 771d
  SEC Form 4 filed by Kaufmann Petra

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 771d
  SEC Form 3 filed by new insider Kaufmann Petra

  3 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 786d
  SEC Form 4 filed by Booth Bruce

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 786d
  SEC Form 4 filed by Bruhn Suzanne Louise

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 786d
  SEC Form 4 filed by Blanchard Cheryl R

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 790d
  SEC Form 4 filed by Verni Christopher

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 790d
  SEC Form 4 filed by Ziolkowski Jennifer Lynn

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 790d
  SEC Form 4 filed by Magovcevic-Liebisch Ivana

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 790d
  SEC Form 4 filed by Gray David L. F.

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 892d
  Magovcevic-Liebisch Ivana bought $15,000 worth of shares (4,000 units at $3.75), increasing direct ownership by 2% to 207,687 units (SEC Form 4)

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 997d
  SEC Form 4 filed by Silber Christopher

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 997d
  SEC Form 3 filed by new insider Silber Christopher

  3 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 1056d
  SEC Form 4 filed by Bruhn Suzanne Louise

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)